Seminars in Diagnostic Pathology
Volume 24, Issue 4 , Pages 217-226 , November 2007

Histochemical identification of Methicillin-resistant Staphylococcus aureus: contribution to preventing nosocomial infection

  • Ryoichi Shimomura, MD

      Affiliations

    • Corresponding Author InformationAddress reprint requests and correspondence: Ryoichi Shimomura, MD, Department of Pathology, Fujita Health University School of Medicine, Toyoake, Aichi 470-1192, Japan.
    • ,
  • Yutaka Tsutsumi, MD

References 

  1. Noller AC, McEllistrem MC, Stine OC, et al. Multilocus sequence typing reveals a lack of diversity among Escherichia coli O157:H7 isolates that are distinct by pulsed-field gel electrophoresis. J Clin Microbiol. 2003;41:675–679
  2. Trindade PA, McCulloch JA, Oliveira GA, et al. Molecular techniques for MRSA typing: current issues and perspectives. Braz J Infect Dis. 2003;7:32–43
  3. Malachowa N, Sabat A, Gniadkowski M, et al. Comparison of multiple-locus variable-number tandem-repeat analysis with pulsed-field gel electrophoresis spa typing, and multilocus sequence typing for clonal characterization of Staphylococcus aureus isolates. J Clin Microbiol. 2005;43:3095–3100
  4. Rossney AS, Lawrence MJ, Morgan PM, et al. Epidemiological typing of MRSA isolates from blood cultures taken in Irish hospitals participating in the European Antimicrobial Resistance Surveillance System (1999-2003). Eur J Clin Microbiol Infect Dis. 2006;25:79–89
  5. van Belkum A. Staphylococcal colonization and infection: homeostasis versus disbalance of human (innate) immunity and bacterial virulence. Curr Opin Infect Dis. 2006;19:339–344
  6. Safdar N, Maki DG. The commonality of risk factors for nosocomial colonization and infection with antimicrobial-resistant Staphylococcus aureus, Enterococcus, gram-negative bacilli, Clostridium difficile, and Candida. Ann Intern Med. 2002;136:834–844
  7. Boyce JM. MRSA patients: proven methods to treat colonization and infection. J Hosp Infect. 2001;48(suppl):9–14
  8. Jarvis WR. The epidemiology of colonization. Infect Control Hosp Epidemiol. 1996;17:47–52
  9. Murdoch DR, Anderson TP, Beynon KA, et al. Evaluation of a PCR assay for detection of Streptococcus pneumoniae in respiratory and nonrespiratory samples from adults with community-acquired pneumonia. J Clin Microbiol. 2003;41:63–66
  10. Centers for Disease Control and Prevention (CDC). Vancomycin-resistant Staphylococcus aureus–New York, 2004. Morb Mortal Wkly Rep. 2004;53:322–323
  11. Cizman M. The use and resistance to antibiotics in the community. Int J Antimicrob Agents. 2003;21:297–307
  12. Bassetti M, Melica G, Cenderello G, et al. Gram-positive bacterial resistance (A challenge for the next millennium). Panminerva Med. 2002;44:179–184
  13. Clinical and Laboratory Standards Institute. Methods for Dilution Antimicrobial Susceptibility Tests for Bacteria That Grow Aerobically (ed 7). Approved standard. CLSI publication no. M7-A7. Wayne, PA: Clinical and Laboratory Standards Institute; 2006;
  14. Cleven BE, Palka-Santini M, Gielen J, et al. Identification and characterization of bacterial pathogens causing bloodstream infections by DNA microarray. J Clin Microbiol. 2006;44:2389–2397
  15. Palka-Santini M, Putzfeld S, Cleven BE, et al. Rapid identification, virulence analysis and resistance profiling of Staphylococcus aureus by gene segment-based DNA microarrays: application to blood culture post-processing. J Microbiol Methods. 2007;68:468–477
  16. Brown DF, Edwards DI, Hawkey PM, et al. Guidelines for the laboratory diagnosis and susceptibility testing of methicillin-resistant Staphylococcus aureus (MRSA). J Antimicrob Chemother. 2005;56:1000–1018
  17. Ubukata K, Nonoguchi R, Matsuhashi M, et al. Expression and inducibility in Staphylococcus aureus of the mecA gene, which encodes a methicillin-resistant S. aureus-specific penicillin-binding protein. J Bacteriol. 1989;171:2882–2885
  18. Song MD, Wachi M, Doi M, et al. Evolution of an inducible penicillin-target protein in methicillin-resistant Staphylococcus aureus by gene fusion. FEBS Lett. 1987;221:167–171
  19. Katayama Y, Ito T, Hiramatsu K. A new class of genetic element Staphylococcus Cassette Chromosome mec, encodes methicillin resistance in Staphylococcus aureus. Antimicrob Agents Chemother. 2000;44:1549–1555
  20. Hiramatsu K, Cui L, Kuroda M, et al. The emergence and evolution of methicillin-resistant Staphylococcus aureus. Trends Microbiol. 2001;9:486–493
  21. Kuroda M, Ohta T, Uchiyama I, et al. Whole genome sequencing of methicillin-resistant Staphylococcus aureus. Lancet. 2001;357:1225–1240
  22. Hartman BJ, Tomasz A. Low-affinity penicillin-binding protein associated with beta-lactam resistance in Staphylococcus aureus. J Bacteriol. 1984;158:513–516
  23. Grundmann H, Aires-de-Sousa M, Boyce J, et al. Emergence and resurgence of meticillin-resistant Staphylococcus aureus as a public-health threat. Lancet. 2006;368:874–885
  24. National Nosocomial Infections Surveillance (NNIS) System Report, data summary from January 1992 through June 2004, issued October 2004. Am J Infect Control. 2004;32:470–485
  25. European Antimicrobial Resistance Surveillance System (EARSS) Annual Report 2005. Available at http://www.rivm.nl/earss/Images/EARSS%202005_tcm61-34899.pdf. Accessed in April 11, 2007.
  26. Nimmo GR, Bell JM, Collignon PJ, et al. Fifteen years of surveillance by the Australian Group for Antimicrobial Resistance (AGAR). Commun Dis Intell. 2003;27(suppl):47–54
  27. Verhoef J, Beaujean D, Blok H, et al. Dutch approach to Methicillin-resistant Staphylococcus aureus. Eur J Clin Microbiol Infect Dis. 1999;18:461–466
  28. Japanese Nosocomial Infection Surveillance (JANIS). Available at http://www.nih-janis.jp/report/index.html (in Japanese). Accessed April 11, 2007.
  29. Jevons MP. “Celbenin”-resistant Staphylococci. Br Med J. 1961;1:124–125
  30. Barrett FF, McGehee RF, Finland M. Methicillin-resistant Staphylococcus aureus at Boston City Hospital (Bacteriologic and epidemiologic observations). N Engl J Med. 1968;279:441–448
  31. Crossley K, Loesch D, Landesman B, et al. An outbreak of infections caused by strains of Staphylococcus aureus resistant to methicillin and aminoglycosides (I. Clinical studies). J Infect Dis. 1979;139:273–279
  32. Collins JK, Mader JT, Kelly MT. Resistance of methicillin-resistant Staphylococcus aureus to third-generation cephalosporins. J Infect Dis. 1983;147:591
  33. Ito T, Katayama Y, Asada K, et al. Structural comparison of three types of staphylococcal cassette chromosome mec integrated in the chromosome in methicillin-resistant Staphylococcus aureus. Antimicrob Agents Chemother. 2001;45:1323–1336
  34. Centers for Disease Control and Prevention. Community-acquired methicillin-resistant Staphylococcus aureus infections—Michigan. Morb Mortal Wkly Rep. 1981;30:185–187
  35. Centers for Community-Acquired Disease Control and Prevention. Four pediatric deaths from community acquired methicillin-resistant Staphylococcus aureus—Minnesota and North Dakota, 1997-1999. Morb Mortal Wkly Rep. 1999;48:707–710
  36. Dufour P, Gillet Y, Bes M, et al. Community-acquired methicillin-resistant Staphylococcus aureus infections in France: emergence of a single clone that produces Panton-Valentine leukocidin. Clin Infect Dis. 2002;35:819–824
  37. Vandenesch F, Naimi T, Enright MC, et al. Community-acquired methicillin-resistant Staphylococcus aureus carrying Panton-Valentine leukocidin genes: worldwide emergence. Emerg Infect Dis. 2003;9:978–984
  38. Wang CC, Lo WT, Chu ML, et al. Epidemiological typing of community-acquired methicillin-resistant Staphylococcus aureus isolates from children in Taiwan. Clin Infect Dis. 2004;39:481–487
  39. Takizawa Y, Taneike I, Nakagawa S, et al. A Panton-Valentine leucocidin (PVL)-positive community-acquired methicillin-resistant Staphylococcus aureus (MRSA) strain, another such strain carrying a multiple-drug resistance plasmid, and other more-typical PVL-negative MRSA strains found in Japan. J Clin Microbiol. 2005;43:3356–3363
  40. Ma XX, Ito T, Tiensasitorn C, et al. Novel type of staphylococcal cassette chromosome mec identified in community-acquired methicillin-resistant Staphylococcus aureus strains. Antimicrob Agents Chemother. 2002;46:1147–1152
  41. Okuma K, Iwakawa K, Turnidge JD, et al. Dissemination of new methicillin-resistant Staphylococcus aureus clones in the community. J Clin Microbiol. 2002;40:4289–4294
  42. Centers for Disease Control and Prevention (CDC). Staphylococcus aureus resistant to vancomycin–United States, 2002. Morb Mortal Wkly Rep. 2002;51:565–567
  43. Chang S, Sievert DM, Hageman JC, et al. Infection with vancomycin-resistant Staphylococcus aureus containing the vanA resistance gene. N Engl J Med. 2003;348:1342–1347
  44. Brown RC, Hopps HC. Staining of bacteria in tissue sections: a reliable Gram stain method. Am J Clin Pathol. 1973;60:234–240
  45. Engbaek K, Johansen KS, Jensen ME. A new technique for Gram staining paraffin-embedded tissue. J Clin Pathol. 1979;32:187–190
  46. Biesterfeld S, Kraus HL, Reineke T, et al. Analysis of the reliability of manual and automated immunohistochemical staining procedures (A pilot study). Anal Quant Cytol Histol. 2003;25:90–96
  47. Bankfalvi A, Boecker W, Reiner A. Comparison of automated and manual determination of HER2 status in breast cancer for diagnostic use: A comparative methodological study using the Ventana BenchMark automated staining system and manual tests. Int J Oncol. 2004;25:929–935
  48. Arihiro K, Umemura S, Kurosumi M, et al. Comparison of evaluations for hormone receptors in breast carcinoma using two manual and three automated immunohistochemical assays. Am J Clin Pathol. 2007;127:356–365
  49. Bjork I, Petersson BA, Sjoquist J. Some physiochemical properties of protein A from Staphylococcus aureus. Eur J Biochem. 1972;29:579–584
  50. Sjoquist J, Meloun B, Hjelm H. Protein A isolated from Staphylococcus aureus after digestion with lysostaphin. Eur J Biochem. 1972;29:572–578
  51. Hjelm H, Sjodahl J, Sjoquist J. Immunologically active and structurally similar fragments of protein A from Staphylococcus aureus. Eur J Biochem. 1975;57:395–403
  52. Bjorck L, Kronvall G. Purification and some properties of streptococcal protein G, a novel IgG-binding reagent. J Immunol. 1984;133:969–974
  53. Akerstrom B, Brodin T, Reis K, et al. Protein G: a powerful tool for binding and detection of monoclonal and polyclonal antibodies. J Immunol. 1985;135:2589–2592
  54. Akerstrom B, Bjorck L. A physicochemical study of protein G, a molecule with unique immunoglobulin G-binding properties. J Biol Chem. 1986;261:10240–10247
  55. Bjorck L. Protein L: a novel bacterial cell wall protein with affinity for immunoglobulin light chains. J Immunol. 1988;140:1194–1197
  56. Akerstrom B, Bjorck L. Protein L: an immunoglobulin light chain-binding bacterial protein (Characterization of binding and physicochemical properties). J Biol Chem. 1989;264:19740–19746
  57. Beckingham JA, Bottomley SP, Hinton R, et al. Interactions between a single immunoglobulin-binding domain of protein L from Peptostreptococcus magnus and a human kappa light chain. Biochem J. 1999;340:193–199
  58. Nakatomi Y, Sugiyama J. A rapid latex agglutination assay for the detection of penicillin-binding protein 2′. J Clin Microbiol. 2007;45:698–706
  59. Sasano H, Imatani A, Shizawa S, et al. Cell proliferation and apoptosis in normal and pathologic human adrenal. Mod Pathol. 1995;8:11–17
  60. Goldstein NS, Ferkowicz M, Odish E, et al. Minimum formalin fixation time for consistent estrogen receptor immunohistochemical staining of invasive breast carcinoma. Am J Clin Pathol. 2003;120:86–92
  61. Heymer B, Smith TB, Haferkamp O. Immunofluorescent histological demonstration of bacteria (Staphylococcus) in formalin fixed and paraffin embedded tissue. Frankf Z Pathol. 1967;77:141–149
  62. Szeredi L, Makrai L, Denes B. Rapid immunohistochemical detection of Rhodococcus equi in impression smears from affected foals on postmortem examination. J Vet Med B Infect Dis Vet Public Health. 2001;48:751–758
  63. Guarner J, Bartlett J, Reagan S, et al. Immunohistochemical evidence of Clostridium sp. Staphylococcus aureus, and group A Streptococcus in severe soft tissue infections related to injection drug use. Hum Pathol. 2006;37:1482–1488
  64. Macabeo-Ong M, Ginzinger DG, Dekker N, et al. Effect of duration of fixation on quantitative reverse transcription polymerase chain reaction analyses. Mod Pathol. 2002;15:979–987
  65. Petersen BL, Sorensen MC, Pedersen S. Fluorescence in situ hybridization on formalin-fixed and paraffin-embedded tissue: optimizing the method. Appl Immunohistochem Mol Morphol. 2004;12:259–265
  66. Guiot Y, Rahier J. The effects of varying key steps in the non-radioactive in situ hybridization protocol: a quantitative study. Histochem J. 1995;27:60–68
  67. Chung JY, Braunschweig T, Hewitt SM. Optimization of recovery of RNA from formalin-fixed, paraffin-embedded tissue. Diagn Mol Pathol. 2006;15:229–236
  68. Inoue T, Nabeshima K, Kataoka H, et al. Feasibility of archival non-buffered formalin-fixed and paraffin-embedded tissues for PCR amplification: an analysis of resected gastric carcinoma. Pathol Int. 1996;46:997–1004
  69. Erdtmann-Vourliotis M, Mayer P, Riechert U, et al. Rational design of oligonucleotide probes to avoid optimization steps in in situ hybridization. Brain Res Brain Res Protoc. 1999;4:82–91
  70. Koji T, Nakane PK. Recent advances in molecular histochemical techniques: in situ hybridization and southwestern histochemistry. J Electron Microsc (Tokyo). 1996;45:119–127
  71. Darby IA, Bisucci T, Desmouliere A, et al. In situ hybridization using cRNA probes: isotopic and nonisotopic detection methods. Methods Mol Biol. 2006;326:17–31
  72. Egholm M, Buchardt O, Christensen L, et al. PNA hybridizes to complementary oligonucleotides obeying the Watson-Crick hydrogen-bonding rules. Nature. 1993;365:566–568
  73. Demidov VV, Yavnilovich MV, Belotserkovskii BP, et al. Kinetics and mechanism of polyamide (“peptide”) nucleic acid binding to duplex DNA. Proc Natl Acad Sci U S A. 1995;92:2637–2641
  74. Stender H, Mollerup TA, Lund K, et al. Direct detection and identification of Mycobacterium tuberculosis in smear-positive sputum samples by fluorescence in situ hybridization (FISH) using peptide nucleic acid (PNA) probes. Int J Tuberc Lung Dis. 1999;3:830–837
  75. Letertre C, Perelle S, Dilasser F, et al. Evaluation of the performance of LNA and MGB probes in 5′-nuclease PCR assays. Mol Cell Probes. 2003;17:307–311
  76. Ugozzoli LA, Latorra D, Puckett R, et al. Real-time genotyping with oligonucleotide probes containing locked nucleic acids. Anal Biochem. 2004;324:143–152
  77. Kubota K, Ohashi A, Imachi H, et al. Improved in situ hybridization efficiency with locked-nucleic-acid-incorporated DNA probes. Appl Environ Microbiol. 2006;72:5311–5317
  78. Thomsen R, Nielsen PS, Jensen TH. Dramatically improved RNA in situ hybridization signals using LNA-modified probes. RNA. 2005;11:1745–1748
  79. Yamashita S. Heat-induced antigen retrieval: mechanisms and application to histochemistry. Prog Histochem Cytochem. 2007;41:141–200
  80. Tesch GH, Lan HY, Nikolic-Paterson DJ. Treatment of tissue sections for in situ hybridization. Methods Mol Biol. 2006;326:1–7
  81. Speel EJ, Hopman AH, Komminoth P. Tyramide signal amplification for DNA and mRNA in situ hybridization. Methods Mol Biol. 2006;326:33–60
  82. Holm R. A highly sensitive nonisotopic detection method for in situ hybridization. Appl Immunohistochem Mol Morphol. 2000;8:162–165
  83. Navarre WW, Schneewind O. Surface proteins of Gram-positive bacteria and mechanisms of their targeting to the cell wall envelope. Microbiol Mol Biol Rev. 1999;63:174–229
  84. Peters RP, Savelkoul PH, Simoons-Smit AM, et al. Faster identification of pathogens in positive blood cultures by fluorescence in situ hybridization in routine practice. J Clin Microbiol. 2006;44:119–123
  85. Gonzalez V, Padilla E, Gimenez M, et al. Rapid diagnosis of Staphylococcus aureus bacteremia using S. aureus PNA FISH. Eur J Clin Microbiol Infect Dis. 2004;23:396–398
  86. Oliveira K, Brecher SM, Durbin A, et al. Direct identification of Staphylococcus aureus from positive blood culture bottles. J Clin Microbiol. 2003;41:889–891
  87. Nagai K, Davies TA, Jacobs MR, et al. Effects of amino acid alterations in penicillin-binding proteins (PBPs) 1a, 2b, and 2x on PBP affinities of penicillin, ampicillin, amoxicillin, cefditoren, cefuroxime, cefprozil, and cefaclor in 18 clinical isolates of penicillin-susceptible, -intermediate, and -resistant pneumococci. Antimicrob Agents Chemother. 2002;46:1273–1280
  88. Sanbongi Y, Ida T, Ishikawa M, et al. Complete sequences of six penicillin-binding protein genes from 40 Streptococcus pneumoniae clinical isolates collected in Japan. Antimicrob Agents Chemother. 2004;48:2244–2250
  89. Bradford PA. Extended-spectrum beta-lactamases in the 21st century: characterization, epidemiology, and detection of this important resistance threat. Clin Microbiol Rev. 2001;14:933–951
  90. Yoshida R, Kuwahara-Arai K, Baba T, et al. Physiological and molecular analysis of a mecA-negative Staphylococcus aureus clinical strain that expresses heterogeneous methicillin resistance. J Antimicrob Chemother. 2003;51:247–255
  91. Sakoulas G, Gold HS, Venkataraman L, et al. Physiological and molecular analysis of a mecA-negative Staphylococcus aureus clinical strain that expresses heterogeneous methicillin resistance. J Clin Microbiol. 2001;39:3946–3951
  92. Chambers HF. Methicillin resistance in staphylococci: Molecular and biochemical basis and clinical implications. Clin Microbiol Rev. 1997;10:781–791

PII: S0740-2570(07)00095-0

doi: 10.1053/j.semdp.2007.07.004

Seminars in Diagnostic Pathology
Volume 24, Issue 4 , Pages 217-226 , November 2007

Article Tools

* Image Usage & Resolution